The modular molecular-biology laboratory CZU mobiLAB 2.0 will enable scientific analysis (RT-qPCR) and diagnostics even in remote and field locations. The speed and accuracy of the analysis will allow end-users to monitor research results in real-time directly at the site of interest. A practical example could be the in-situ monitoring of African Swine Fever directly in high-risk areas. The capability for rapid response and the immediate implementation of containment measures on-site could significantly limit damage in such cases. A certified methodology for detecting WNV and LB under field conditions can aid in accurate mapping of the occurrence of these dangerous pathogens directly at the site. Necessary preventive measures can then be undertaken immediately and effectively in problematic areas.
Given the broad application range of molecular diagnostic methods like qPCR, the laboratory can be utilized across various scientific and diagnostic fields. Probable users of CZU mobiLAB 2.0 include research teams focused on molecular sample analysis and specialized veterinary, or medical organizations involved in pathogen diagnostics. The laboratory will be capable of processing a wide range of samples, from environmental (water, soil, plants) to veterinary (faeces, hair, tissue) and medical (blood, saliva, swabs). The versatility and accessibility of CZU mobiLAB 2.0 will provide the possibility for rapid, efficient, and specific molecular analysis to a broad spectrum of users, pushing the boundaries of diagnostics and scientific analysis beyond research centres and healthcare facilities.
This project was supported by the Technology Agency of the Czech Republic (TAČR) under the SIGMA programme, Subprogramme 4, DC1: Support for “Proof of Concept” activities, project registration number TACR2315001.